Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Ioannis Androulakis"'
Autor:
Ioannis Androulakis, Rob M.C. Mestrom, Sergio Curto, Inger-Karine K. Kolkman-Deurloo, Gerard C. van Rhoon
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 31, Iss , Pp 100606- (2024)
Background and purpose: Integrating simultaneous interstitial hyperthermia in high-dose-rate brachytherapy treatments (HDR-BT) is expected to lead to enhanced therapeutic effect. However, there is currently no device available for such an integration
Externí odkaz:
https://doaj.org/article/a07e8d387e134732b9e9cd9d83efe664
Autor:
Rodis D. Paparodis, Ioannis Androulakis, Dimitrios Askitis, Ilias Perogamvros, Nicholaos Angelopoulos, Andreas Rizoulis, Sarantis Livadas, Anastasios Boniakos
Publikováno v:
Endocrines, Vol 5, Iss 2, Pp 124-136 (2024)
Purpose: Lipid lowering treatments (LLTs) can reduce the risk of atherosclerotic cardiovascular disease (ASCVD). Despite the availability of potent LLTs, our clinical observations suggest an inadequate use of such agents. To evaluate this treatment d
Externí odkaz:
https://doaj.org/article/51d4c9a312e14265869de2adb8433dfb
Autor:
Nicholas Angelopoulos, Rodis D. Paparodis, Ioannis Androulakis, Panagiotis Anagnostis, Anastasios Boniakos, Leonidas Duntas, Spyridon N. Karras, Sarantis Livadas
Publikováno v:
Thyroid Research, Vol 16, Iss 1, Pp 1-7 (2023)
Abstract Background In the last decade, the combination of the widespread use of streptavidin–biotin technology and biotin–containing supplements (BCS) in the daily clinical practice, have led to numerous reports of erroneous hormone immunoassay
Externí odkaz:
https://doaj.org/article/7d53bd21235c418e8688d500db136b07
Autor:
Nicholas Angelopoulos, Rodis D. Paparodis, Ioannis Androulakis, Anastasios Boniakos, Panagiotis Anagnostis, Vasilis Tsimihodimos, Sarantis Livadas
Publikováno v:
Nutraceuticals, Vol 3, Iss 1, Pp 1-12 (2022)
The objective of the present study was to assess the lipid-lowering efficacy and safety of a novel dietary supplement containing monacolin K combined with the coenzyme Q10 and grape seed and olive tree leaf extracts (Arichol®®) on the lipid profile
Externí odkaz:
https://doaj.org/article/6258446e103d4f8992c49087e7539baf
Autor:
Ioannis Androulakis, Kemal Sumser, Melanie N. D. Machielse, Linetta Koppert, Agnes Jager, Remi Nout, Martine Franckena, Gerard C. van Rhoon, Sergio Curto
Publikováno v:
International Journal of Hyperthermia, Vol 39, Iss 1, Pp 1213-1221 (2022)
Objective The addition of hyperthermia in the treatment of intact breast cancer with the aim to improve local response is currently in a research phase. First, optimal hyperthermia devices need to be developed, for which a diverse, anatomically and p
Externí odkaz:
https://doaj.org/article/c7ce882001884b0d9c9a99d4e9cbd581
Autor:
Sarantis Livadas, Christina Bothou, Justyna Kuliczkowska-Płaksej, Ralitsa Robeva, Andromahi Vryonidou, Jelica Bjekic Macut, Ioannis Androulakis, Milica Opalic, Zadalla Mouslech, Andrej Milewicz, Alessandra Gambineri, Dimitrios Panidis, Djuro Macut
Publikováno v:
Endocrine Connections, Vol 11, Iss 4, Pp 1-12 (2022)
Background: Polycystic ovary syndrome (PCOS) is considered a risk factor f or the development of type 2 diabetes mellitus (T2DM). However, which is the most appropriate way to evaluate dysglycemia in women with PCOS and who are at i ncreased risk are
Externí odkaz:
https://doaj.org/article/4dac4e3935c14336ab4b02d74810612d
Autor:
Ioannis Androulakis, Riccardo Ferrero, Rogier van Oossanen, Alessandra Manzin, Antonia G. Denkova, Kristina Djanashvili, Robin Nadar, Gerard C. van Rhoon
Publikováno v:
Sensors, Vol 23, Iss 9, p 4514 (2023)
While hyperthermia has been shown to induce a variety of cytotoxic and sensitizing effects on cancer tissues, the thermal dose–effect relationship is still not well quantified, and it is still unclear how it can be optimally combined with other tre
Externí odkaz:
https://doaj.org/article/11ba973b8c0e4a94bd03dbf394a3e795
Autor:
Ioannis Androulakis, Rob M. C. Mestrom, Miranda E. M. C. Christianen, Inger-Karine K. Kolkman-Deurloo, Gerard C. van Rhoon
Publikováno v:
International Journal of Hyperthermia, Vol 38, Iss 1, Pp 1660-1671 (2021)
Objective: In High Dose Rate Brachytherapy for prostate cancer there is a need for a new way of increasing cancer cell kill in combination with a stable dose to the organs at risk. In this study, we propose a novel ThermoBrachy applicator that offers
Externí odkaz:
https://doaj.org/article/834d7e11b6184a3facab3b26b46bd212
Autor:
Riccardo Ferrero, Ioannis Androulakis, Luca Martino, Robin Nadar, Gerard C. van Rhoon, Alessandra Manzin
Publikováno v:
Sensors, Vol 22, Iss 10, p 3610 (2022)
The evaluation of the biological effects of therapeutic hyperthermia in oncology and the precise quantification of thermal dose, when heating is coupled with radiotherapy or chemotherapy, are active fields of research. The reliable measurement of hyp
Externí odkaz:
https://doaj.org/article/8624933a1a9f43d59775b2a755723acf
Autor:
Ioannis Androulakis, Rob M. C. Mestrom, Miranda E. M. C. Christianen, Inger-Karine K. Kolkman-Deurloo, Gerard C. van Rhoon
Publikováno v:
Sensors, Vol 22, Iss 4, p 1328 (2022)
The combination of interstitial hyperthermia treatment (IHT) with high dose rate brachytherapy (HDR-BT) can improve clinical outcomes since it highly enhances the efficiency of cell kill, especially when applied simultaneously. Therefore, we have dev
Externí odkaz:
https://doaj.org/article/7e8a76f09bc4457a9f2ee25d950b4fdf